General Information of Drug (ID: DR1919)
Drug Name
BRN-4179169
Synonyms
Procysteine; L-2-Oxothiazolidine-4-carboxylate; Oxothiazolidine carboxylate, L-; (4R)-2-oxo-1,3-thiazolidine-4-carboxylic acid; (4R)-2-oxo-4-thiazolidinecarboxylic acid; (R)-(-)-2-Oxothiazolidine-4-carboxylic acid; (R)-2-Oxo-4-thiazolidinecarboxylic acid; (R)-2-Oxothiazolidine-4-carboxylic acid; 19771-63-2; 2-Oxothiazolidine-4-carboxylate, L-; 4-Thiazolidinecarboxylic acid, 2-oxo-, (4R)-; BRN 4179169; CCRIS 7672; CHEMBL442218; L-2-Oxo-4-thiazolidinecarboxylic acid; L-2-Oxothiazolidine-4-carboxylic acid; UNII-X7063P804E
Indication Amyotrophic lateral sclerosis [ICD11: 8B60] Phase 2 [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 147.15 Topological Polar Surface Area 91.7
Heavy Atom Count 9 Rotatable Bond Count 1
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 4
Cross-matching ID
PubChem CID
72390
ChEBI ID
CHEBI:125673
CAS Number
19771-63-2
TTD Drug ID
D0M0UT
Formula
C4H5NO3S
Canonical SMILES
C1C(NC(=O)S1)C(=O)O
InChI
1S/C4H5NO3S/c6-3(7)2-1-9-4(8)5-2/h2H,1H2,(H,5,8)(H,6,7)/t2-/m0/s1
InChIKey
BMLMGCPTLHPWPY-REOHCLBHSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Cysteine DM001531
5862
Unclear 1 [3]
Glutathione DM003449
124886
Unclear 1 [3]
Mercaptopyruvate DM003450
98
Unclear 1 [3]
PYR DM000331
107735
Unclear 1 [3]
Cysteamine DM003761
6058
Unclear 2 [3]
Cysteine sulfate DM006796 N. A. Unclear 2 [3]
Lactate DM003259
91435
Unclear 2 [3]
PYR DM000331
107735
Unclear 2 [3]
Cysteate DM003454
25701
Unclear 3 [3]
Hypotaurine DM003447
107812
Unclear 3 [3]
Lactate DM003259
91435
Unclear 3 [3]
Taurine DM003084
1123
Unclear 4 [3]
⏷ Show the Full List of 12  DM(s)
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR007364 BRN-4179169 Cysteine Unclear Unclear [3]
MR007372 BRN-4179169 Mercaptopyruvate Unclear Unclear [3]
MR007375 BRN-4179169 Pyruvate Unclear Unclear [3]
MR007376 BRN-4179169 Glutathione Unclear Unclear [3]
MR007365 Cysteine Cysteamine Unclear Unclear [3]
MR007368 Cysteine Cysteine sulfate Unclear Unclear [3]
MR007373 Mercaptopyruvate Pyruvate Unclear Unclear [3]
MR007366 Cysteamine Hypotaurine Unclear Unclear [3]
MR007369 Cysteine sulfate Hypotaurine Unclear Unclear [3]
MR007370 Cysteine sulfate Cysteate Unclear Unclear [3]
MR007374 Pyruvate Lactate Unclear Unclear [3]
MR007371 Cysteate Taurine Unclear Unclear [3]
MR007367 Hypotaurine Taurine Unclear Unclear [3]
⏷ Show the Full List of 13 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Pyroglutamase (OPLAH) DME0560 Homo sapiens
OPLA_HUMAN
3.5.2.9
[2]
References
1 ClinicalTrials.gov (NCT00002114) A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides.
2 Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines. Carcinogenesis. 2007 Feb;28(2):378-89.
3 Non-invasive monitoring of L-2-oxothiazolidine-4-carboxylate metabolism in the rat brain by in vivo 13C magnetic resonance spectroscopy

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.